XLID98 · NEXMIF · KIAA2022 · MRX98 Connecting families. Accelerating research. Changing lives.

Turning discovery into hope.

We are families, clinicians, researchers, and supporters from around the world, united to improve lives affected by XLID98. Working together, we can accelerate treatments and a cure for a lifelong neurodevelopmental condition caused by changes in the NEXMIF gene.

A smiling girl standing outdoors on a beach, the sea and evergreens behind her.

Different Names, Same Condition

NEXMIF, KIAA2022, KIDLIA, if any of these terms sound familiar, you are in the RIGHT place. X-linked Intellectual Developmental Disorder-98 is a neurodevelopmental condition caused by a problem with the NEXMIF or KIAA2022 gene that affects neuron function and development in the brain.

The four names for one condition. NEXMIF: the current gene name, the official gene name that causes XLID98. KIAA2022: the former gene name, used before NEXMIF was adopted. KIDLIA: an alternative clinical name used in clinical and research settings. MRX98: a historical disorder name. XLID98 is the name used by the XLID98 Foundation.

You are not alone.

Joining Forces: The XLID98 Foundation

When someone gets diagnosed with an ultra-rare condition, many questions have no answers. Real families joined forces to create the XLID98 Foundation. We are driven to gather information, provide support, highlight interventions … and discover a CURE!

Where would you like to go next?

New to the medical terms? Our glossary explains them in plain language. Terms with a dotted underline link to it, and on a computer you can hover over one to see a quick definition without leaving the page.

Stay Connected

Be the first to hear about new research, family events, and ways to help.

Join Our Mailing List

Our priorities

How We're Making a Difference

We focus on four strategic priority areas. Here are some of our key initiatives.

  • Advancing Understanding

    We are establishing the XLID98 International Registry to learn how this condition affects everyone.

  • Building Community

    We host a virtual International Conference each spring, bringing families, researchers, and clinicians together to share their expertise.

  • Supporting Science

    We build relationships with leading researchers around the world to support gene therapy, medical treatments, and the search for a CURE.

  • Promoting Advocacy

    Rare diseases need grassroots effort. We support fundraising and spread awareness, because we are not alone.

Our reach

Accelerating the Path to Solutions Around the World

We are a small but mighty group of families determined to transform life for our children. Together we can turn our hope into scientific advancements, each step bringing us closer to the reality of gene therapy for XLID98 / NEXMIF and a brighter future for children everywhere.

  • 344

    Identified worldwide, and growing each month.

    A family of three standing together in a sunny garden.
  • 40+ Countries

    With verified XLID98 / NEXMIF cases.

  • 3 Research Labs

    Working toward effective treatments and a gene therapy cure.

    • Queen's University Dr. Jagdeep Walia
    • University College London Dr. Gabriele Lignani
    • Boston University Dr. Heng-Ye Man

Our community

Faces of XLID98

Meet all the children

Together, We Can Find a Cure

Every family deserves hope.

Together, we are bringing families, clinicians, and researchers together from around the world to accelerate research, support gene therapy, and improve the lives of people affected by XLID98 / NEXMIF.

Your support helps turn hope into action.

A laughing young boy in an orange t-shirt at his classroom desk.

News & events

The Latest From the Foundation

Colorful hand-drawn lettering reading "A Day in the Life".

XLID98 - A Day in the Life

What does a day in the life look like for a child with XLID98 (NEXMIF)? A family shares the routines, therapies, and small wins that fill their days.

View All News & Events

Our Partners & Collaborators

Working with trusted organizations to advance research, support families, and accelerate progress.